#### UCVSFYFrrKh3ZXGlmyiJ05_Q
#### SELECT * FROM DAvidKanal WHERE `Chan` ="UCVSFYFrrKh3ZXGlmyiJ05_Q"
BASE
:::::::: SELECT * FROM DAvidKanal WHERE Chan="UCVSFYFrrKh3ZXGlmyiJ05_Q"
#~~~~# SELECT * FROM DAvidKanal WHERE Chan="UCVSFYFrrKh3ZXGlmyiJ05_Q"
#~~~~# http://chegu.de/Ausgabe.php?URL=https://www.youtube.com/feeds/videos.xml?channel_id=UCVSFYFrrKh3ZXGlmyiJ05_Q
**20708
**?xml version="1.0" encoding="UTF-8"?>
feed xmlns:yt="http://www.youtube.com/xml/schemas/2015" xmlns:media="http://search.yahoo.com/mrss/" xmlns="http://www.w3.org/2005/Atom">
link rel="self" href="http://www.youtube.com/feeds/videos.xml?channel_id=UCVSFYFrrKh3ZXGlmyiJ05_Q"/>
id>yt:channel:VSFYFrrKh3ZXGlmyiJ05_Q/id>
yt:channelId>VSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>hVIVO plc/title>
link rel="alternate" href="https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2020-07-27T12:27:18+00:00/published>
entry>
id>yt:video:GGm0c35fz08/id>
yt:videoId>GGm0c35fz08/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>Laboratory Team Leader at hVIVO/title>
link rel="alternate" href="https://www.youtube.com/watch?v=GGm0c35fz08"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2024-01-16T07:07:07+00:00/published>
updated>2024-04-12T11:58:57+00:00/updated>
media:group>
media:title>Laboratory Team Leader at hVIVO/media:title>
media:content url="https://www.youtube.com/v/GGm0c35fz08?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i4.ytimg.com/vi/GGm0c35fz08/hqdefault.jpg" width="480" height="360"/>
media:description>We are delighted to introduce Sofia Zhao, our Laboratory đŹ Team Leader at hVIVO!
Sofia shares her day-to-day tasks and discusses what makes working at hVIVO so special. đ Dive into the exciting world of our laboratory and discover why she enjoys being a part of our team!
Ready to join us? Explore the possibilities on our careers page./media:description>
media:community>
media:starRating count="5" average="5.00" min="1" max="5"/>
media:statistics views="155"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:8DPBi_GF_I8/id>
yt:videoId>8DPBi_GF_I8/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>Year in Review 2023/title>
link rel="alternate" href="https://www.youtube.com/watch?v=8DPBi_GF_I8"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-12-28T08:00:03+00:00/published>
updated>2024-04-26T16:07:06+00:00/updated>
media:group>
media:title>Year in Review 2023/media:title>
media:content url="https://www.youtube.com/v/8DPBi_GF_I8?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i1.ytimg.com/vi/8DPBi_GF_I8/hqdefault.jpg" width="480" height="360"/>
media:description>2023 was a fantastic year of achievements for the hVIVO Group! Throughout the year we have unlocked a new region, expanded our facilities, developed new models & much more!
We are delighted to share our year in review video for 2023, providing a closer look at some of the key highlights of the year that not only showcase our successes but also reinforces our position as the world's leading provider of human challenge trials đ
hVIVO - set to transform global healthcare by revolutionising the drug development process through scientific ingenuity/media:description>
media:community>
media:starRating count="5" average="5.00" min="1" max="5"/>
media:statistics views="99"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:HmlBmDxAqLA/id>
yt:videoId>HmlBmDxAqLA/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>Ask the Experts: A Deep Dive Into Human Challenge Trials/title>
link rel="alternate" href="https://www.youtube.com/watch?v=HmlBmDxAqLA"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-12-21T15:39:14+00:00/published>
updated>2024-03-14T20:20:18+00:00/updated>
media:group>
media:title>Ask the Experts: A Deep Dive Into Human Challenge Trials/media:title>
media:content url="https://www.youtube.com/v/HmlBmDxAqLA?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i1.ytimg.com/vi/HmlBmDxAqLA/hqdefault.jpg" width="480" height="360"/>
media:description>This hVIVO audio event, focusing on human challenge studies (also known as Controlled Human Infection Model or CHIM studies), is a highly informative and engaging Q&A session. The event feature two speakers Bruno Speder VP, Regulatory Affairs & Consultancy Services and Nicolas Noulin Director Clinical Science, moderated by Egle Pavyde, Director Business Development EMEA&APAC.
Bruno Speder addresses the intricate regulatory affairs aspects, providing insights into the guidelines, compliance requirements, and legal frameworks governing these studies.
Nicolas Noulin delves into the clinical and scientific nuances of human challenge studies. This include discussions on the design, and implementation of these studies, as well as their significance in clinical research./media:description>
media:community>
media:starRating count="4" average="5.00" min="1" max="5"/>
media:statistics views="192"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:9htq4Gs31YQ/id>
yt:videoId>9htq4Gs31YQ/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>Development Scientist at hVIVO/title>
link rel="alternate" href="https://www.youtube.com/watch?v=9htq4Gs31YQ"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-10-30T06:00:03+00:00/published>
updated>2024-04-26T05:44:11+00:00/updated>
media:group>
media:title>Development Scientist at hVIVO/media:title>
media:content url="https://www.youtube.com/v/9htq4Gs31YQ?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i2.ytimg.com/vi/9htq4Gs31YQ/hqdefault.jpg" width="480" height="360"/>
media:description>Meet our Development Scientist at hVIVO.
If you are interested in working for hVIVO, you can search and apply for job vacancies on our website./media:description>
media:community>
media:starRating count="5" average="5.00" min="1" max="5"/>
media:statistics views="61"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:8nq5V2aXLDA/id>
yt:videoId>8nq5V2aXLDA/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>Associate Medical Director Role at hVIVO/title>
link rel="alternate" href="https://www.youtube.com/watch?v=8nq5V2aXLDA"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-10-06T05:00:08+00:00/published>
updated>2024-04-26T15:24:20+00:00/updated>
media:group>
media:title>Associate Medical Director Role at hVIVO/media:title>
media:content url="https://www.youtube.com/v/8nq5V2aXLDA?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i1.ytimg.com/vi/8nq5V2aXLDA/hqdefault.jpg" width="480" height="360"/>
media:description>hVIVO plc is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
Search and apply for available roles on our website./media:description>
media:community>
media:starRating count="3" average="5.00" min="1" max="5"/>
media:statistics views="79"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:ek6_v0w5XrQ/id>
yt:videoId>ek6_v0w5XrQ/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>hVIVO Canary Wharf Facilities - Adam French/title>
link rel="alternate" href="https://www.youtube.com/watch?v=ek6_v0w5XrQ"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-09-20T05:55:34+00:00/published>
updated>2024-04-10T07:47:52+00:00/updated>
media:group>
media:title>hVIVO Canary Wharf Facilities - Adam French/media:title>
media:content url="https://www.youtube.com/v/ek6_v0w5XrQ?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i2.ytimg.com/vi/ek6_v0w5XrQ/hqdefault.jpg" width="480" height="360"/>
media:description>Adam French, VP of Clinical Operations catches up with Rosie from BRR Media to discuss hVIVO's new state-of-the-art facilities in Canary Wharf, due to open in 2024. The expansion, largely funded by hVIVO clients, comes in response to the Company's growing orderbook and increasing demand for its human challenge trial services./media:description>
media:community>
media:starRating count="5" average="5.00" min="1" max="5"/>
media:statistics views="364"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:jlHTPWwBzFQ/id>
yt:videoId>jlHTPWwBzFQ/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>hVIVO Careers - Fueling Scientific Research/title>
link rel="alternate" href="https://www.youtube.com/watch?v=jlHTPWwBzFQ"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-09-18T05:00:17+00:00/published>
updated>2024-02-25T09:17:00+00:00/updated>
media:group>
media:title>hVIVO Careers - Fueling Scientific Research/media:title>
media:content url="https://www.youtube.com/v/jlHTPWwBzFQ?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i3.ytimg.com/vi/jlHTPWwBzFQ/hqdefault.jpg" width="480" height="360"/>
media:description>At hVIVO we work as one team on our mission is to deliver todayâs healthcare by empowering tomorrowâs innovation.
We are a diverse group of individuals working for one team to achieve common goals. Each one of us plays a crucial role in the team's success. We are committed to each other and the team. We learn from our failures together and celebrate our successes together. Diversity and inclusion are at the core of our organisation, and we consider our clientsâ success as our own.
We are pioneering in our approach, always curious. We use our unique scientific expertise to guide our clientâs towards successful outcomes. We embrace new opportunities and rise to new challenges. Our agility allows us to redefine our markets and be highly responsive to our clientsâ requirements.
Search and Apply:
https://hvivo.com/careers//media:description>
media:community>
media:starRating count="6" average="5.00" min="1" max="5"/>
media:statistics views="368"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:7T3xIcmb6yk/id>
yt:videoId>7T3xIcmb6yk/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>Developing an Influenza B Human Challenge Model/title>
link rel="alternate" href="https://www.youtube.com/watch?v=7T3xIcmb6yk"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-07-31T06:02:44+00:00/published>
updated>2024-04-26T08:24:40+00:00/updated>
media:group>
media:title>Developing an Influenza B Human Challenge Model/media:title>
media:content url="https://www.youtube.com/v/7T3xIcmb6yk?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i4.ytimg.com/vi/7T3xIcmb6yk/hqdefault.jpg" width="480" height="360"/>
media:description>Dr. Andrew Catchpole, Chief Scientific Officer discusses hVIVO's bespoke human challenge model development services focusing on our most recent #FluB model. He highlights the various stages of this contract & the fundamental steps hVIVO takes to ensure success.
Andrew also provides an overview of Influenza B and how this model differs from our other #influenza human challenge models./media:description>
media:community>
media:starRating count="5" average="5.00" min="1" max="5"/>
media:statistics views="187"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:WhA3RMdNVAI/id>
yt:videoId>WhA3RMdNVAI/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>VP of Clinical Operations on hVIVO's new Facility/title>
link rel="alternate" href="https://www.youtube.com/watch?v=WhA3RMdNVAI"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-07-27T15:18:57+00:00/published>
updated>2024-03-14T10:05:18+00:00/updated>
media:group>
media:title>VP of Clinical Operations on hVIVO's new Facility/media:title>
media:content url="https://www.youtube.com/v/WhA3RMdNVAI?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i4.ytimg.com/vi/WhA3RMdNVAI/hqdefault.jpg" width="480" height="360"/>
media:description>Adam French, hVIVO's VP of Clinical Operations, discusses how the new facilities will impact the Company's lab performance./media:description>
media:community>
media:starRating count="3" average="5.00" min="1" max="5"/>
media:statistics views="260"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:zlXqa8GrUY4/id>
yt:videoId>zlXqa8GrUY4/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>hVIVO to Develop hMPV Human Challenge Model/title>
link rel="alternate" href="https://www.youtube.com/watch?v=zlXqa8GrUY4"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-06-29T05:45:02+00:00/published>
updated>2024-04-25T10:59:56+00:00/updated>
media:group>
media:title>hVIVO to Develop hMPV Human Challenge Model/media:title>
media:content url="https://www.youtube.com/v/zlXqa8GrUY4?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i3.ytimg.com/vi/zlXqa8GrUY4/hqdefault.jpg" width="480" height="360"/>
media:description>Our Chief Scientific Officer discusses hMPV & how hVIVO to develop human metapneumovirus (hMPV) challenge model./media:description>
media:community>
media:starRating count="2" average="5.00" min="1" max="5"/>
media:statistics views="138"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:N5GbnHs4W7I/id>
yt:videoId>N5GbnHs4W7I/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>Human Challenge Trials: Supporting the development of ânext generationâ COVID-19 Vaccines/title>
link rel="alternate" href="https://www.youtube.com/watch?v=N5GbnHs4W7I"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-05-18T09:03:27+00:00/published>
updated>2024-04-26T04:25:38+00:00/updated>
media:group>
media:title>Human Challenge Trials: Supporting the development of ânext generationâ COVID-19 Vaccines/media:title>
media:content url="https://www.youtube.com/v/N5GbnHs4W7I?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i3.ytimg.com/vi/N5GbnHs4W7I/hqdefault.jpg" width="480" height="360"/>
media:description>Our VP of Regulatory Affairs presented at a Topra webinar on 15 May 2023, to discuss Human Challenge Trials: Supporting the development of ânext generationâ COVID-19 Vaccines./media:description>
media:community>
media:starRating count="3" average="5.00" min="1" max="5"/>
media:statistics views="161"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:X_YQ4JxJdG4/id>
yt:videoId>X_YQ4JxJdG4/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>hVIVO at World Vaccine Congress Washington 2023/title>
link rel="alternate" href="https://www.youtube.com/watch?v=X_YQ4JxJdG4"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-04-14T13:14:27+00:00/published>
updated>2024-03-15T00:19:39+00:00/updated>
media:group>
media:title>hVIVO at World Vaccine Congress Washington 2023/media:title>
media:content url="https://www.youtube.com/v/X_YQ4JxJdG4?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i1.ytimg.com/vi/X_YQ4JxJdG4/hqdefault.jpg" width="480" height="360"/>
media:description>Chief Scientific Officer, Andrew Catchpole discusses hVIVO's attendance at the World Vaccine Congress in Washington./media:description>
media:community>
media:starRating count="11" average="5.00" min="1" max="5"/>
media:statistics views="340"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:D0mhHKyMLSM/id>
yt:videoId>D0mhHKyMLSM/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>Director of Business Development Egle Payvde Discusses BioEurope Spring Event/title>
link rel="alternate" href="https://www.youtube.com/watch?v=D0mhHKyMLSM"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-03-30T08:43:57+00:00/published>
updated>2024-04-27T01:25:39+00:00/updated>
media:group>
media:title>Director of Business Development Egle Payvde Discusses BioEurope Spring Event/media:title>
media:content url="https://www.youtube.com/v/D0mhHKyMLSM?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i1.ytimg.com/vi/D0mhHKyMLSM/hqdefault.jpg" width="480" height="360"/>
media:description>/media:description>
media:community>
media:starRating count="4" average="5.00" min="1" max="5"/>
media:statistics views="267"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:4zMOrirIqRs/id>
yt:videoId>4zMOrirIqRs/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>Venn Life Sciences new offices at Leiden BioScience Park/title>
link rel="alternate" href="https://www.youtube.com/watch?v=4zMOrirIqRs"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-03-29T08:45:05+00:00/published>
updated>2024-04-26T14:48:33+00:00/updated>
media:group>
media:title>Venn Life Sciences new offices at Leiden BioScience Park/media:title>
media:content url="https://www.youtube.com/v/4zMOrirIqRs?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i1.ytimg.com/vi/4zMOrirIqRs/hqdefault.jpg" width="480" height="360"/>
media:description>/media:description>
media:community>
media:starRating count="5" average="5.00" min="1" max="5"/>
media:statistics views="234"/>
/media:community>
/media:group>
/entry>
entry>
id>yt:video:OfCYqES_h8U/id>
yt:videoId>OfCYqES_h8U/yt:videoId>
yt:channelId>UCVSFYFrrKh3ZXGlmyiJ05_Q/yt:channelId>
title>hVIVO Omicron Human Challenge Model/title>
link rel="alternate" href="https://www.youtube.com/watch?v=OfCYqES_h8U"/>
author>
name>hVIVO plc/name>
uri>https://www.youtube.com/channel/UCVSFYFrrKh3ZXGlmyiJ05_Q/uri>
/author>
published>2023-03-20T09:08:30+00:00/published>
updated>2024-04-26T07:11:45+00:00/updated>
media:group>
media:title>hVIVO Omicron Human Challenge Model/media:title>
media:content url="https://www.youtube.com/v/OfCYqES_h8U?version=3" type="application/x-shockwave-flash" width="640" height="390"/>
media:thumbnail url="https://i4.ytimg.com/vi/OfCYqES_h8U/hqdefault.jpg" width="480" height="360"/>
media:description>/media:description>
media:community>
media:starRating count="8" average="5.00" min="1" max="5"/>
media:statistics views="242"/>
/media:community>
/media:group>
/entry>
/feed>
hVIVO plc
01.08.2023 ˇ 19:27:12 ˇˇˇ
01.01.1970 ˇ 01:00:00 ˇˇˇ
26.07.2023 ˇ 04:16:35 ˇˇˇ 5 ˇˇˇ ˇˇˇ 26 ˇˇˇ
31.07.2024 ˇ 01:50:05 ˇˇˇ
01.01.1970 ˇ 01:00:00 ˇˇˇ
26.07.2023 ˇ 04:16:35 ˇˇˇ 5 ˇˇˇ ˇˇˇ 26 ˇˇˇ
1:: Laboratory Team Leader at hVIVO
01.01.1970 ˇ 01:00:00 ˇˇˇ 16.01.2024 ˇ 07:07:07 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ We are delighted to introduce Sofia Zhao, our Laboratory 🔬 Team Leader at hVIVO!
Sofia shares her day-to-day tasks and discusses what makes working at hVIVO so special. 🚀 Dive into the exciting world of our laboratory and discover why she enjoys being a part of our team!
Ready to join us? Explore the possibilities on our careers page.
2:: Year in Review 2023
01.01.1970 ˇ 01:00:00 ˇˇˇ 28.12.2023 ˇ 08:00:03 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ 2023 was a fantastic year of achievements for the hVIVO Group! Throughout the year we have unlocked a new region, expanded our facilities, developed new models & much more!
We are delighted to share our year in review video for 2023, providing a closer look at some of the key highlights of the year that not only showcase our successes but also reinforces our position as the world's leading provider of human challenge trials 🌍
hVIVO - set to transform global healthcare by revolutionising the drug development process through scientific ingenuity
3:: Ask the Experts: A Deep Dive Into Human Challenge Trials
01.01.1970 ˇ 01:00:00 ˇˇˇ 21.12.2023 ˇ 15:39:14 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ This hVIVO audio event, focusing on human challenge studies (also known as Controlled Human Infection Model or CHIM studies), is a highly informative and engaging Q&A session. The event feature two speakers Bruno Speder VP, Regulatory Affairs & Consultancy Services and Nicolas Noulin Director Clinical Science, moderated by Egle Pavyde, Director Business Development EMEA&APAC.
Bruno Speder addresses the intricate regulatory affairs aspects, providing insights into the guidelines, compliance requirements, and legal frameworks governing these studies.
Nicolas Noulin delves into the clinical and scientific nuances of human challenge studies. This include discussions on the design, and implementation of these studies, as well as their significance in clinical research.
4:: Development Scientist at hVIVO
01.01.1970 ˇ 01:00:00 ˇˇˇ 30.10.2023 ˇ 06:00:03 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ Meet our Development Scientist at hVIVO.
If you are interested in working for hVIVO, you can search and apply for job vacancies on our website.
5:: Associate Medical Director Role at hVIVO
01.01.1970 ˇ 01:00:00 ˇˇˇ 06.10.2023 ˇ 05:00:08 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ hVIVO plc is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and therapeutics using human challenge clinical trials. The Group provides end-to-end early clinical development services to its large, established and growing repeat client base, which includes four of the top 10 largest global biopharma companies.
Search and apply for available roles on our website.
6:: hVIVO Canary Wharf Facilities - Adam French
01.01.1970 ˇ 01:00:00 ˇˇˇ 20.09.2023 ˇ 05:55:34 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ Adam French, VP of Clinical Operations catches up with Rosie from BRR Media to discuss hVIVO's new state-of-the-art facilities in Canary Wharf, due to open in 2024. The expansion, largely funded by hVIVO clients, comes in response to the Company's growing orderbook and increasing demand for its human challenge trial services.
7:: hVIVO Careers - Fueling Scientific Research
01.01.1970 ˇ 01:00:00 ˇˇˇ 18.09.2023 ˇ 05:00:17 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ At hVIVO we work as one team on our mission is to deliver today’s healthcare by empowering tomorrow’s innovation.
We are a diverse group of individuals working for one team to achieve common goals. Each one of us plays a crucial role in the team's success. We are committed to each other and the team. We learn from our failures together and celebrate our successes together. Diversity and inclusion are at the core of our organisation, and we consider our clients’ success as our own.
We are pioneering in our approach, always curious. We use our unique scientific expertise to guide our client’s towards successful outcomes. We embrace new opportunities and rise to new challenges. Our agility allows us to redefine our markets and be highly responsive to our clients’ requirements.
Search and Apply:
https://hvivo.com/careers/
8:: Developing an Influenza B Human Challenge Model
01.01.1970 ˇ 01:00:00 ˇˇˇ 31.07.2023 ˇ 06:02:44 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ Dr. Andrew Catchpole, Chief Scientific Officer discusses hVIVO's bespoke human challenge model development services focusing on our most recent #FluB model. He highlights the various stages of this contract & the fundamental steps hVIVO takes to ensure success.
Andrew also provides an overview of Influenza B and how this model differs from our other #influenza human challenge models.
9:: VP of Clinical Operations on hVIVO's new Facility
01.01.1970 ˇ 01:00:00 ˇˇˇ 27.07.2023 ˇ 15:18:57 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ Adam French, hVIVO's VP of Clinical Operations, discusses how the new facilities will impact the Company's lab performance.
10:: hVIVO to Develop hMPV Human Challenge Model
01.01.1970 ˇ 01:00:00 ˇˇˇ 29.06.2023 ˇ 05:45:02 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ Our Chief Scientific Officer discusses hMPV & how hVIVO to develop human metapneumovirus (hMPV) challenge model.
11:: Human Challenge Trials: Supporting the development of ‘next generation’ COVID-19 Vaccines
01.01.1970 ˇ 01:00:00 ˇˇˇ 18.05.2023 ˇ 09:03:27 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ Our VP of Regulatory Affairs presented at a Topra webinar on 15 May 2023, to discuss Human Challenge Trials: Supporting the development of ‘next generation’ COVID-19 Vaccines.
12:: hVIVO at World Vaccine Congress Washington 2023
01.01.1970 ˇ 01:00:00 ˇˇˇ 14.04.2023 ˇ 13:14:27 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ Chief Scientific Officer, Andrew Catchpole discusses hVIVO's attendance at the World Vaccine Congress in Washington.
13:: Director of Business Development Egle Payvde Discusses BioEurope Spring Event
01.01.1970 ˇ 01:00:00 ˇˇˇ 30.03.2023 ˇ 08:43:57 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ
14:: Venn Life Sciences new offices at Leiden BioScience Park
01.01.1970 ˇ 01:00:00 ˇˇˇ 29.03.2023 ˇ 08:45:05 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ
15:: hVIVO Omicron Human Challenge Model
01.01.1970 ˇ 01:00:00 ˇˇˇ 20.03.2023 ˇ 09:08:30 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ
16:: Venn Life Sciences €3.2m Contract Win with Global Pharma Company
01.01.1970 ˇ 01:00:00 ˇˇˇ 18.01.2023 ˇ 06:55:48 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ €3.2m contract for Venn Life Sciences with global pharmaceutical client.
The contract commences in January 2023, with the Venn team in Breda providing dedicated complex clinical pharmacokinetics (“PK”) consultancy and programming services to this global pharmaceutical client on a number of drug development programmes across multiple therapeutic areas, to study the absorption, distribution and excretion of drugs within the body.
17:: Year in Review 2022 - hVIVO Group
01.01.1970 ˇ 01:00:00 ˇˇˇ 03.01.2023 ˇ 13:35:51 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ
18:: CEO Yamin 'Mo' Khan on Name Change to hVIVO plc
01.01.1970 ˇ 01:00:00 ˇˇˇ 26.10.2022 ˇ 11:00:48 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ
19:: Lab Accreditation Awarded to hVIVO
01.01.1970 ˇ 01:00:00 ˇˇˇ 01.09.2022 ˇ 06:59:24 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ Our VP of Clinical Operations catches up with BRR Media to discuss Lab Accreditation award.
20:: Alex Mann discusses hVIVO's new Influenza contract - BRR Media
01.01.1970 ˇ 01:00:00 ˇˇˇ 22.08.2022 ˇ 10:53:01 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ Our Senior Director of Clinical Science Alex Mann Catches up with BRR Media to discuss hVIVO's new contract with a Big Pharma Client. Alex discusses the significance of influenza research & hVIVO's role in this study.
21:: £6.2m Influenza human challenge study contract - BRR Media
01.01.1970 ˇ 01:00:00 ˇˇˇ 05.08.2022 ˇ 05:45:01 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ hVIVO, a subsidiary of Open Orphan plc, has signed a £6.2m contract with a US-based biotechnology company to test its antiviral candidate using the hVIVO Influenza A human challenge study model.
The human challenge study is expected to commence in H2 2022 and will be conducted at hVIVO's state-of-the-art facilities in London. The Company expects the revenue from the contract to be recognised across 2022 and 2023.
22:: hVIVO's £7.2m RSV Human Challenge Model Contract
01.01.1970 ˇ 01:00:00 ˇˇˇ 14.06.2022 ˇ 09:16:19 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ
23:: hVIVO £14.7m Challenge virus manufacturing contract for top 5 global pharmaceutical client
01.01.1970 ˇ 01:00:00 ˇˇˇ 01.06.2022 ˇ 13:45:40 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ Our Chief Scientific Officer, Andrew Catchpole & Senior Director of Clinical Science, Alex Mann catches up with BRR Media to discuss hVIVO's £14.7m Challenge virus manufacturing contract for top 5 global pharmaceutical client.
24:: Chief Scientific Officer on Influenza Challenge Study contract Win
01.01.1970 ˇ 01:00:00 ˇˇˇ 19.05.2022 ˇ 05:45:01 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ
25:: Open Orphan's CEO on hVIVO's first ever Phase II field study site study awarded
01.01.1970 ˇ 01:00:00 ˇˇˇ 06.05.2022 ˇ 06:50:20 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ
26:: Chief Scientific Officer, Dr Andrew Catchpole, discusses how hVIVO manufacture challenge agents
01.01.1970 ˇ 01:00:00 ˇˇˇ 04.05.2022 ˇ 08:10:49 ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ ˇˇˇ